CEO Total Pay
$4.3M
FY2025 Summary Compensation, below median
The CEO earned $4.3M in FY2025 against median worker pay of $198,541 · Measuring Instruments.
Data updated August 2026
Subscribe to Pacific Biosciences Of California, Inc. CEO pay filing updates (RSS)
Answer first
According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $198,541. Industry placement uses the FY2025 SIC-38 peer cohort (# 79 of 86, 9th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Measuring Instruments companies.
Pacific Biosciences Of California, Inc. CEO pay vs. every FY2025 complete filing
Total CEO compensation, the full national distribution, this company marked
$4,309,846 31st percentile higher than 31% of 1,423 companies
Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025
CEO total pay ($4.3M) against pay ratio (22:1) for Pacific Biosciences Of California, Inc. (marked) and its 5 closest same-industry peers, against the Measuring Instruments industry median on both axes.
Exclusive CEO-to-median-worker bands across 80 complete latest-FY filings in SIC 38. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in Pacific Biosciences Of California, Inc.'s structured SEC pay-ratio disclosure. See our methodology →
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $2.8M | - | $257,461 | 11:1 | - |
| 2022 | $6.6M | +134% | $232,626 | 28:1 | +17:1 |
| 2023 | $8.0M | +22% | $366,784 | 22:1 | -6:1 |
| 2024 | $9.2M | +14% | $199,372 | 46:1 | +24:1 |
| 2025 | $4.3M | -53% | $198,541 | 22:1 | -24:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1299130, FY2021–2025. Adjacent-year deltas only.
Pacific Biosciences Of California, Inc.'s FY2025 ratio 22:1 ranks #79 of 86 Measuring Instruments filers (9th percentile). the CEO earned 22× the median employee ($198,541) in FY2025.
At $198,541 median worker pay, the FLOOR stamp is near pay-parity territory under MID$ CEO total.
CEO Total Pay
$4.3M
FY2025 Summary Compensation, below median
Pay Ratio
22:1
Below typical
Pacific Biosciences Of California, Inc.'s FY2025 ratio 22:1 ranks #79 of 86 Measuring Instruments filers (9th percentile). The structured pay-ratio disclosure reports the total without line-item components. Measuring Instruments (SIC 38) median ratio is 121:1 across 86 FY2025 filers; Pacific Biosciences Of California, Inc.'s $4.3M CEO total is at or below the $8.0M industry median CEO pay.
Dollar rank #979 and ratio rank #1197 split - treat 22:1 as a disclosure, not a fairness score. Open Measuring Instruments peers.
Read our methodology - how this data is sourced, computed, and verified. Pacific Biosciences Of California, Inc.'s FY2025 ratio 22:1 ranks #79 of 86 Measuring Instruments filers (9th percentile).
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MID$ · ELITE-MED.
ABS(ceo_total_comp) peer at $4.3M (Δ $9K lighter vs Pacific Biosciences Of California, Inc.); MODEST · HIGH-MED vs this page's FLOOR · MID$ · ELITE-MED.
ABS(ceo_total_comp) peer at $4.3M (Δ $9K heavier vs Pacific Biosciences Of California, Inc.); MID · PAR-MED vs this page's FLOOR · MID$ · ELITE-MED.
ABS(ceo_total_comp) peer at $4.3M (Δ $10K lighter vs Pacific Biosciences Of California, Inc.); MODEST · HIGH-MED vs this page's FLOOR · MID$ · ELITE-MED.
ABS(ceo_total_comp) peer at $4.3M (Δ $22K lighter vs Pacific Biosciences Of California, Inc.); MODEST · HIGH-MED vs this page's FLOOR · MID$ · ELITE-MED.
Outset Medical, Inc. stamps FLOOR · MICRO nearest in-SIC by ABS(pay_ratio) to Pacific Biosciences Of California, Inc.'s FLOOR filing.
Pacific Biosciences Of California, Inc.'s FY2025 package sits #979 by CEO dollars and #1197 by ratio under MID$ · FLOOR.
Pacific Biosciences Of California, Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.